SE9803623D0 - New therapeutic application - Google Patents

New therapeutic application

Info

Publication number
SE9803623D0
SE9803623D0 SE9803623A SE9803623A SE9803623D0 SE 9803623 D0 SE9803623 D0 SE 9803623D0 SE 9803623 A SE9803623 A SE 9803623A SE 9803623 A SE9803623 A SE 9803623A SE 9803623 D0 SE9803623 D0 SE 9803623D0
Authority
SE
Sweden
Prior art keywords
new therapeutic
therapeutic application
analogues
mammals
lipid
Prior art date
Application number
SE9803623A
Other languages
English (en)
Inventor
Mats Rudling
Bo Angelin
Original Assignee
Sahltech Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sahltech Ab filed Critical Sahltech Ab
Priority to SE9803623A priority Critical patent/SE9803623D0/sv
Publication of SE9803623D0 publication Critical patent/SE9803623D0/sv
Priority to AT99970604T priority patent/ATE305795T1/de
Priority to AU14288/00A priority patent/AU764779B2/en
Priority to JP2000576870A priority patent/JP2002527486A/ja
Priority to US09/830,077 priority patent/US6559289B1/en
Priority to EP99970604A priority patent/EP1124571B1/en
Priority to CA002342794A priority patent/CA2342794A1/en
Priority to DE69927599T priority patent/DE69927599T2/de
Priority to PCT/SE1999/001898 priority patent/WO2000023097A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/27—Growth hormone [GH], i.e. somatotropin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00—Peptide or protein sequence
    • Y10S930/01—Peptide or protein sequence
    • Y10S930/12—Growth hormone, growth factor other than t-cell or b-cell growth factor, and growth hormone releasing factor; related peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Zoology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Organic Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
SE9803623A 1998-10-22 1998-10-22 New therapeutic application SE9803623D0 (sv)

Priority Applications (9)

Application Number Priority Date Filing Date Title
SE9803623A SE9803623D0 (sv) 1998-10-22 1998-10-22 New therapeutic application
AT99970604T ATE305795T1 (de) 1998-10-22 1999-10-21 Verwendung von wachstumshormon und analoga davon für die behandlung von säugern mit familiärer hypercholesterolämie
AU14288/00A AU764779B2 (en) 1998-10-22 1999-10-21 Use of growth hormone or analogues thereof for the treatment of mammals with familial hypercholesterolemia
JP2000576870A JP2002527486A (ja) 1998-10-22 1999-10-21 家族性高コレステロール血症をもつ哺乳動物の治療のための成長ホルモンまたはその類似体の使用
US09/830,077 US6559289B1 (en) 1998-10-22 1999-10-21 Use of growth hormone or analogues thereof for the treatment of mammals with familial hypercholesterolemia
EP99970604A EP1124571B1 (en) 1998-10-22 1999-10-21 Use of growth hormone or analogues thereof for the treatment of mammals with familial hypercholesterolemia
CA002342794A CA2342794A1 (en) 1998-10-22 1999-10-21 Use of growth hormone or analogues thereof for the treatment of mammals with familial hypercholesterolemia
DE69927599T DE69927599T2 (de) 1998-10-22 1999-10-21 Verwendung von wachstumshormon und analoga davon für die behandlung von säugern mit familiärer hypercholesterolämie
PCT/SE1999/001898 WO2000023097A1 (en) 1998-10-22 1999-10-21 Use of growth hormone or analogues thereof for the treatment of mammals with familial hypercholesterolemia

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9803623A SE9803623D0 (sv) 1998-10-22 1998-10-22 New therapeutic application

Publications (1)

Publication Number Publication Date
SE9803623D0 true SE9803623D0 (sv) 1998-10-22

Family

ID=20413054

Family Applications (1)

Application Number Title Priority Date Filing Date
SE9803623A SE9803623D0 (sv) 1998-10-22 1998-10-22 New therapeutic application

Country Status (9)

Country Link
US (1) US6559289B1 (sv)
EP (1) EP1124571B1 (sv)
JP (1) JP2002527486A (sv)
AT (1) ATE305795T1 (sv)
AU (1) AU764779B2 (sv)
CA (1) CA2342794A1 (sv)
DE (1) DE69927599T2 (sv)
SE (1) SE9803623D0 (sv)
WO (1) WO2000023097A1 (sv)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7785567B2 (en) * 2002-08-23 2010-08-31 Valorisation-Recherche, Société en Commandite Growth hormone-releasing peptides in the treatment or prevention of atherosclerosis and hypercholesterolemia
EA200601392A1 (ru) * 2004-01-29 2006-12-29 Апплайд Резеч Системз Арс Холдинг Н. В. Способы и композиции для лечения липодистрофии
KR100969085B1 (ko) * 2007-09-05 2010-07-09 현대자동차주식회사 하이브리드 차량용 동력전달장치

Also Published As

Publication number Publication date
CA2342794A1 (en) 2000-04-27
US6559289B1 (en) 2003-05-06
DE69927599D1 (de) 2006-02-16
AU764779B2 (en) 2003-08-28
EP1124571A1 (en) 2001-08-22
WO2000023097A1 (en) 2000-04-27
AU1428800A (en) 2000-05-08
ATE305795T1 (de) 2005-10-15
JP2002527486A (ja) 2002-08-27
EP1124571B1 (en) 2005-10-05
DE69927599T2 (de) 2006-07-20

Similar Documents

Publication Publication Date Title
AU7031500A (en) Therapeutic quinazoline compounds
ATE322280T1 (de) Verwendung von daptomycin
NO20101190L (no) Anvendelse av buprenorfin i fremstillingen av et medikament
DE69736441D1 (de) Pharmazeutische zusammensetzung zur behandlung von neurologischen und neuropsychiatrischen erkrankungen
HUP0402661A3 (en) Formulation and dosage form for the controlled delivery of therapeutic agents
IL195723A (en) Use of p53 inhibitors for the preparation of medicament
DE60121988D1 (de) Kombinationstherapie mit antidiabetischen und antikonvulsiven mitteln
DE69807634D1 (de) Medizinische einrichtung zur verabreichung von therapeutischen wirkstoffen
DE69838099D1 (de) Quinazolinenon-enthaltende pharmazeutische zusammensetzungen zur verhütung von gefässneubildung und zur behandlung von bösartigen neubildungen
HUP0301380A3 (en) Use of rosuvastatin (zd-4522) for producing pharmaceutical composition using in the treatment of heterozygous familial hypercholesterolemia
AU2002213698A1 (en) Needleless syringe for the subcutaneous delivery of therapeutic agents
DE60024414T2 (de) Oxadiazolverbindungen und -zusammensetzungen zur abgabe von wirkstoffen
BRPI0410049A (pt) composto ou um sal ou estereoisÈmero farmaceuticamente aceitável do mesmo, uso de um composto, composição farmacêutica, e, kit farmacêutico
DE60016460D1 (de) Verwendungen und zusammenstellungen von nitratestern als sedativa
EA199900246A1 (ru) Фармацевтические соединения
GB9907571D0 (en) Compounds
EA200000242A1 (ru) Применение фанхинона для лечения болезни альцгеймера
SE9803623D0 (sv) New therapeutic application
HUP0000110A2 (hu) Azaciklusos, azabiciklusos vagy tetrahidropiridinszármazékokat tartalmazó, fájdalom kezelésére alkalmas gyógyászati készítmények
SE0004827D0 (sv) Therapeutic compounds
ATE299704T1 (de) Warmgeformte feste arzneizusammensetzung zur gesteuerten wirkstoffabgabe von perindopril
BR0206918A (pt) Uso de iloperidona
IL125983A0 (en) Pharmaceutical composition comprising factor xiiia
ZA977042B (en) Nasal administration of agents for treatment of delayed onset emesis.
MX9707719A (es) Preparado en combinacion que contiene tramadol y un antagonista del canal de calcio.